Uroplasty Provides Update On PTNS Reimbursement |
December 04, 2013 | December 2013 Bond Updates |
MINNEAPOLIS, Dec. 4, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today provided an update on reimbursement coverage for Percutaneous... |
View more at: http://www.prnewswire.com/news-releases/uroplasty-provides-update-on-ptns-reimbursement-234386421.html |
Related News |
|